12 Aug
2020

Intellectual property on demand

As covid-19 cases continued to soar in many parts of the world through the summer, IAM asked a group of leading law firms to assess how governments might relax IP rights in relation to a vaccine or other treatments

Richard Lloyd

Editor

IAM magazine

[email protected]

Adam Houldsworth

Life sciences reporter

IAM

[email protected]

Jacob Schindler

Asia-Pacific editor

[email protected]